Biotech Values

[rkrw]

Actually Pfizer never dropped the partnership, contrary they seemed to be expanding and even nominated a new compound 2 weeks ago. So Pfizer didn't flee and coly went down for good reason, their seminal trial was a bust. So maybe the truth is the opposite, pfizer sticking around and reupping was a good sign.